Zynteglo Authorization Renewal Paused While EU Regulators Examine Safety Concerns

 
• By Neena Brizmohun
  
Gene therapy
Zynteglo is a gene therapy for beta thalassaemia • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography